Abstract:Abstract:Objective To study the expression levels of p16,p53,CDK4/cyclinD1 protein in breast cancer and their relationship to prognosis. 〖WTHZ〗Methods〓〖WTBZ〗The expression of p16,p53,CDK4 and cyclinD1 in breast cancer tissues of 86 patients who did not receive preoperative chemotherapy were examined,and the relationship of their expression to clinicopathological data were analyzed.〖WTHZ〗Results〓〖WTBZ〗(1)p16,p53,CDK4:The positive expression of p16,p53 and CDK4 were significantly different in stages I and II infiltrating ductal carcinoma,but cyclin D showed no difference;their positive expression in lymph node negative and lymph node positive groups were significantly different;their positive expression for patients′age≤50 years and>50 years showed no significat difference;there was significant difference of p53 expression between ER negative and ER positive groups,but p16,CDK4 and cyclin D expression showed no difference;p53 expression was significantly different in ER negative and PR positive groups,but the levels of the other proteins were not significantly different.(2)There were significant differences between the expression of p16 and p53